AZN - ASTRAZENECA - Share Chat

AstraZeneca Plc (AZN) is a global, science-led biopharmaceutical company headquartered in Cambridge, UK, and a prominent FTSE 100 constituent. It focuses on the discovery, development, manufacturing, and commercialisation of prescription medicines. The company operates across three key therapeutic areas: Oncology, Biopharmaceuticals (covering Cardiovascular, Renal & Metabolism, and Respiratory & Immunology), and Rare Diseases, following the acquisition of Alexion.

Renowned for its robust R&D pipeline and commitment to innovation, AstraZeneca consistently brings new therapies to market, addressing significant unmet medical needs worldwide. Its strong global presence and leadership in key disease categories underpin its status as a major player in the pharmaceutical sector, driving both health outcomes and shareholder value.